ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development

Proceedings of the National Academy of Sciences, Volume 122, Issue 12, March 2025.
SignificanceProstate cancer typically relies on male hormones for growth; however, prolonged hormone therapy can lead to a more aggressive form known as neuroendocrine prostate cancer (NEPC), which is resistant to treatment. This study identifies E26 …
Read More